You are here

biobucks

Scribe's CRISPR tech Prevails in new $1.5B biobucks deal with Lilly unit

Scribe's CRISPR tech Prevails in new $1.5B biobucks deal with Lilly unit

Fierce Biotech

Scribe Therapeutics

Prevail Therapeutics

Jennifer Doudna

Flag link:

Zymeworks, Daiichi end $293M bispecific collab after 6 unfruitful years

Zymeworks, Daiichi end $293M bispecific collab after 6 unfruitful years

Fierce Biotech

immuno-oncology

Flag link:

Roche offers up to $554M in biobucks to in-need Kronos for small-molecule discovery pact

Roche offers up to $554M in biobucks to in-need Kronos for small-molecule discovery pact

Fierce Biotech

small molecule drugs

Flag link:

AbbVie inks Immunome solid tumor deal that could top $2.8B in biobucks

AbbVie inks Immunome solid tumor deal that could top $2.8B in biobucks

Fierce Biotech

Flag link:

Roche further taps drug discovery spinout's Nimble tech in $1.1B biobucks deal

Roche further taps drug discovery spinout's Nimble tech in $1.1B biobucks deal

Fierce Biotech

Nimble Therapeutics

Flag link:

Altamira finds buyer for Zilentin inner ear unit so Swiss biotech can go all-in on RNA

Altamira finds buyer for Zilentin inner ear unit so Swiss biotech can go all-in on RNA

Fierce Biotech

Altamira Therapeutics

Flag link:

'There are no rules': BMS enters lawless land of molecular degraders with $550M SyntheX deal

'There are no rules': BMS enters lawless land of molecular degraders with $550M SyntheX deal

Fierce Biotech

Bristol Myers Squibb

molecular degraders

Flag link:

China's Jemincare nabs $650M biobucks pact with Roche's Genentech for prostate cancer hopeful

China's Jemincare nabs $650M biobucks pact with Roche's Genentech for prostate cancer hopeful

Fierce Biotech

prostate cancer

Flag link:

Sanofi signs $1.2B pact with Atomwise in latest high-value AI drug discovery deal

Sanofi signs $1.2B pact with Atomwise in latest high-value AI drug discovery deal

Fierce Biotech

artificial intelligence

Flag link:

Merck is back in Alzheimer's saddle with $1B+ Cerevance pact, years after dropping the BACE

Merck is back in Alzheimer's saddle with $1B+ Cerevance pact, years after dropping the BACE

Fierce Biotech

Alzheimer's disease

Flag link:

Bristol Myers triples-down on Immatics, bringing deal to $4.2B total biobucks

Bristol Myers triples-down on Immatics, bringing deal to $4.2B total biobucks

Fierce Biotech

Bristol Myers Squibb

Flag link:

Boehringer OKs $100M biobucks deal for hearing loss R&D project

Boehringer OKs $100M biobucks deal for hearing loss R&D project

Fierce Biotech

Boehringer Ingelheim

Flag link:

Jazz, Werewolf to howl at the moon together in $1.26B backloaded biobucks pact

Jazz, Werewolf to howl at the moon together in $1.26B backloaded biobucks pact

Fierce Biotech

Jazz Pharmaceuticals

Werewolf Therapeutics

Flag link:

Novartis eyes next-gen AAV gene therapies in $1.75B Voyager biobucks pact

Novartis eyes next-gen AAV gene therapies in $1.75B Voyager biobucks pact

Fierce Biotech

Voyager Therapeutics

AAV gene therapy

Flag link:

Takeda's gene therapy ambitions rise another $2B in 4-program Code Bio pact

Takeda's gene therapy ambitions rise another $2B in 4-program Code Bio pact

Fierce Biotech

Code Biotherapeutics

Flag link:

J&J's Janssen inks $1B biobucks pact for Mersana's ADC tech in 3 targets

J&J's Janssen inks $1B biobucks pact for Mersana's ADC tech in 3 targets

Fierce Biotech

antibody-drug conjugate

Flag link:

Amgen chooses Generate in $1.9B biobucks deal to churn out up to 10 multispecific drugs

Amgen chooses Generate in $1.9B biobucks deal to churn out up to 10 multispecific drugs

Fierce Biotech

Generate Biomedicines

drug development

artificial intelligence

Flag link:

Astellas becomes latest Dyno gene therapy partner with $1.6B biobucks pact to join Roche, Novartis, Sarepta

Astellas becomes latest Dyno gene therapy partner with $1.6B biobucks pact to join Roche, Novartis, Sarepta

Fierce Biotech

Dyno Therapeutics

Flag link:

Vaccibody gets a new name and loads up with nearly $1B in biobucks for new vaccine pact with Regeneron

Vaccibody gets a new name and loads up with nearly $1B in biobucks for new vaccine pact with Regeneron

Endpoints

Nykode Therapeutics

infectious disease

Flag link:

Novartis makes protein degrader play, inking deal with new British startup to access fruits of novel tech

Novartis makes protein degrader play, inking deal with new British startup to access fruits of novel tech

Fierce Biotech

protein degradation

Dunad Therapeutics

Flag link:

Pages